About 3D VetMed
an innovative community using 3D printing to better society
With increasing access and use of 3D printing in veterinary medicine there is unlimited opportunity to expand research and decrease the gap in collaborative markets for sharing information and experiences. The Consortium for 3D Printing in Veterinary Medicine (3D VetMed) is an opportunity to create a space where experts in veterinary 3D printing can collaborate, network, and educate others to advance the field.
3D VetMed was established in the summer of 2019 as an offshoot of RaPPID (Rapid Prototyping of Patient-specific Implants for Dogs) by Dr. Michelle Oblak, Dr. Alex zur Linden, Dr. Fiona James, and Dr. John Phillips, at the Ontario Veterinary College in Ontario, Canada. This team was involved in investigating custom implants and uses of 3D printing technologies in several aspects of veterinary research and clinical practice and noted that this was an area of significant potential. Multiple research veterinary students have also contributed to these groups including Marissa McGaffey, Jordan James, Nathanael Bachynski, Juan Orjuela and Adam Quinlan.
The Importance of 3D Printing
Why is 3D printing revolutionizing the veterinary industry?
New and rapidly evolving
Numerous medical applications
Many veterinary institutions are utilizing 3D printing technologies
At least 8 North American universities use 3D printing in their veterinary programs
What are the applications of 3D printing in medicine?
Educational anatomical and procedural models
Medical implants, devices and surgical tools
DR. MICHELLE OBLAK
Michelle Oblak is a veterinary surgical oncologist and Associate Professor of Soft Tissue and Oncologic Surgery in the Department of Clinical Studies, Ontario Veterinary College. Her research program focuses on translation, innovation and the incorporation of novel techniques and technology in treatment of patients, most often in a clinical trials setting. She has several collaborations considering dogs as a naturally occurring disease model for cancer in humans.
She is a co-director of the University of Guelph Institute for Comparative Cancer Investigation (ICCI), and an active member of the Dog Osteosarcoma Group: Biomarkers of Neoplasia (DOG BONe) and Rapid prototyping of patient-specific implants for dogs (RaPPID) working group. Michelle also serves as the Chair of the Veterinary Society of Surgical Oncology (VSSO) Research Committee, an international organization that works to advance the understanding and surgical treatment of veterinary patients with cancer.
DR. FIONA JAMES
Fiona James earned a Master’s degree in Neuroscience at the University of Western Ontario before completing her Doctor of Veterinary Medicine (DVM) degree at the Ontario Veterinary College. After an internship in Michigan, she returned to the OVC for both a residency in Neurology and a Doctor of Veterinary Science degree. From 2009 to 2011, she was an adjunct faculty member at OVC and a veterinary neurology specialist working at several private practices in Ontario and the U.S. She joined the OVC Neurology Service in 2011. Her research interests include comparative epilepsy, electroencephalography, translational genetics of neurologic disease, neuroimaging, and 3D medical modelling. Currently, she directs the Comparative Epilepsy Program with active projects examining details of canine electroencephalography and epilepsy syndromes. She is also a founding member of the OVC Rapid Prototyping of Patient-specific Implants for Dogs (RaPPID) research group.
DR. ALEXANDER ZUR LINDEN
Alex zur Linden is an Associate professor at the Ontario Veterinary College.
DR. JOHN PHILLIPS
John Phillips PH.D Engineering, is the Digital Haptic Lab manager of RaPPID. John operates and maintains all of the design stations and equipment, assists with design and production solutions, and trains graduate researchers in the use of all of the computing and prototyping tools.